II. Pathophysiology
- Mechanism- Antidiuretic Hormone (ADH) deficiency- Contrast with Nephrogenic Diabetes Insipidus (deficient renal response to ADH)
 
 
- Antidiuretic Hormone (ADH) deficiency
- 
                          Polyuria
                          - Decreased ADH release
 
- Permanent Polyuria- Central lesion above median eminence
 
- Transient Polyuria- Central lesion below median eminence
- ADH passes via Hypothalamus to portal capillaries
- Results in ADH release below the median eminence
 
III. Etiology
- Idiopathic (30%)- Autoimmune Disease (common)- Lymphocyte inflammation- Pituitary stalk (thickened stalk on MRI)
- Posterior pituitary
 
- Anterior Pituitary deficiency- Growth Hormone
- ACTH deficient
 
 
- Lymphocyte inflammation
- Familial Diabetes Insipidus (very rare)- Point mutation in ADH precursor gene- Precursor accumulates
- Toxicity to ADH synthesizing cells
 
- Enhancement within Hypothalamus on MRI
 
- Point mutation in ADH precursor gene
 
- Autoimmune Disease (common)
- 
                          Severe Traumatic Brain Injury
                          - Hypothalamus or pituitary injury
 
- Neurosurgery (Transsphenoidal)- Results from Hypothalamus or Pituitary Trauma
- Most common cause of Polyuria post neurosurgery
- Differential Diagnosis- Excess fluids
- Mannitol
- Corticosteroids
 
- Approach- Check Urine Osmolality
- Observe response to water restriction
 
 
- Malignancy- Examples: Lung Cancer, Leukemia, Lymphoma
- Polyuria may be presenting symptom
 
- Langerhans Histiocytosis (Histiocytosis X)- Infiltrative disease
- Sarcoidosis causes similar infiltration
 
- Post SVT resolution
- Anorexia Nervosa
- Pregnancy exacerbates any of above forms
IV. Diagnosis
- 
                          Fluid Deprivation Test
                          - No response to water deprivation
- Response to exogenous ADH administration
 
- 
                          Hare-Hickey Test
                          - Decreased ADH to Serum Osmolality ratio
 
V. Radiology: MRI Head
- Central DI: Diminished signal at posterior pituitary
VI. Management
- General Measures that potentiate ADH
- dDAVP (Desmopressin)
- 
                          Chlorpropamide 125-250 mg PO qd-bid- Antidiuretic effect - may lower Urine Output by 50%
- Risk of Hypoglycemia at higher doses
 
- 
                          Carbamazepine 100-300 mg bid- Enhances ADH response
- May lower Urine Output by 50%
 
- 
                          Hydrochlorothiazide with low salt intake- Decreases Polyuria
- Dose: 25 mg qd to bid
 
